Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5677331 | NOVARTIS | Antimalarial compositions |
Oct, 2014
(9 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Chemical Entity Exclusivity(NCE) | Apr 07, 2014 |
Orphan Drug Exclusivity(ODE) | Apr 07, 2016 |
NCE-1 date: 07 April, 2013
Market Authorisation Date: 07 April, 2009
Treatment: Treatment of acute, uncomplicated malaria infection due to plasmodium falciparum in patients of 5kg bodyweight and above
Dosage: TABLET;ORAL